AACR Annual Meeting 2023: NCI Director Shares National Cancer Plan
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...
Although a basic assumption of genetics is that all the cells in our body share the same DNA, research...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The new year brings a new chapter in the holy book of cancer biology with the publication in the...
Ten years ago, then-President of the AACR, Tyler Jacks, PhD, FAACR, conceived the idea for a “comprehensive, high-impact journal that would present new...
Editor’s note: As President Joseph R. Biden Jr. took office on Wednesday, Cancer Discovery, a journal of the American...
Racial disparities in incidence and mortality exist for many cancers, prompting researchers to explore social and biological factors that...
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
Immunotherapy research has exploded over the past decade and has led to the approval of seven immune checkpoint inhibitors by the United States Food and Drug Administration (FDA) for the treatment...